A senior official from the Israeli health ministry has defended the price the Israeli government paid for Pfizer’s coronavirus vaccines, saying it was “ridiculously low” compared to the economic cost of a national lockdown.

Israel has vaccinated a bigger proportion of its population than any other country to date, but has faced hard questions over the apparent premium it paid to Pfizer for its shots...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now